Sign in

ALAB on Nasdaq

Astera Labs

American semiconductor company

Astera Labs, Inc., headquartered in San Jose, California, is a fabless manufacturing company that develops connectivity technologies and related software that are used in data centers serving the artificial intelligence and cloud-computing markets.3 Its shares trade on Nasdaq under the symbol ALAB.1 Wikipedia text CC BY-SA 4.0

$290.48 down 9.80 (3.26%)Price as of Oct 15, 2026 at 17:33 UTC

Last updated Oct 21, 2026.

Overview

2017Founded1

Compare with Photronics Inc, Himax or Silicon Motion, or pick any stock.

  • TickerALAB on Nasdaq1
  • Industrysemiconductor industry1
  • HeadquartersSanta Clara1
  • Websitewww.asteralabs.com
  • Incorporated inDE6
  • Business address2345 North First Street, San Jose, Ca 951316
  • Filer categoryLarge accelerated filer6
  • Legal formCorporation4
  • LEI529900LJL8TUEGF7HG204
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressc/o THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST, 19801 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 65936284

See how the biggest companies compare on our leaderboards

Astera Labs, Inc., headquartered in San Jose, California, is a fabless manufacturing company that develops connectivity technologies and related software that are used in data centers serving the artificial intelligence and cloud-computing markets. Its products include the Aries PCIe/Compute Express Link (CXL) smart DSP retimers, which extend the physical reach and improve signal integrity for PCI Express connections in large server clusters; Scorpio smart fabric switches, which provide high-bandwidth GPU-to-GPU interconnects and manage traffic inside AI racks; Taurus ethernet smart cable modules, which advance high-speed ethernet networking infrastructure over copper links; and Leo CXL memory controllers, which facilitate high-speed memory expansion and memory pooling for memory-heavy workloads.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

75.7%Gross margin8
20.3%Operating margin8
25.7%Net margin8
115.1%Revenue growth, 20258
16.1%Return on equity8
$281.8MFree cash flow8

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Regions

Singapore brought in 32% of the revenue Astera Labs broke down this way in fiscal 2025.

  1. Singapore$277.0M832%up 853% from 2024
  2. China$256.3M830%up 253% from 2024
  3. Taiwan$247.4M829%down 8% from 2024
  4. Rest of the world$44.4M85%up 233% from 2024
  5. United States$27.4M83%up 143% from 2024
Regions by year
Regions202320242025
Singapore$0$29.1M$277.0M
China$5.5M$72.7M$256.3M
Taiwan$72.2M$269.9M$247.4M
Rest of the world$7.4M$13.3M$44.4M
United States$30.7M$11.3M$27.4M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue24¢$207.3M
  • Research and development36¢$304.0M
  • Other costs14¢$121.1M
  • Income tax0¢$981.0K
  • Profit26¢$219.1M

Out of $852.5M in revenue.8

Where each dollar of operating cash went, fiscal 2025

  • Capital spending12¢$37.5M
  • Kept or used elsewhere88¢$281.8M

Out of $319.3M of cash from operations.8

Financial statements

Revenue98$852.5M in 2025+967% since 2022
0$250.0M$500.0M$750.0M$1.0B2022: $79.9M$79.9M20222023: $115.8M$115.8M2023+45%2024: $396.3M$396.3M2024+242%2025: $852.5M$852.5M2025+115%
Gross profit98$645.3M in 2025+1000% since 2022
0$200.0M$400.0M$600.0M$800.0M2022: $58.7M$58.7M20222023: $79.8M$79.8M2023+36%2024: $302.7M$302.7M2024+279%2025: $645.3M$645.3M2025+113%
Operating income98$173.4M in 2025
-$200.0M-$100.0M0$100.0M$200.0M2022: -$60.2M-$60.2M20222023: -$29.5M-$29.5M2023−51%2024: -$116.1M-$116.1M2024+293%2025: $173.4M$173.4M2025
Net income98$219.1M in 2025
-$100.0M0$100.0M$200.0M$300.0M2022: -$58.3M-$58.3M20222023: -$26.3M-$26.3M2023−55%2024: -$83.4M-$83.4M2024+218%2025: $219.1M$219.1M2025

Every line of the income statement as filed: the last 3 fiscal years, latest first.8

Period ending2025-12-312024-12-312023-12-31
Revenue$852.5M$396.3M$115.8M
Cost of revenue$207.3M$93.6M$36.0M
Gross profit$645.3M$302.7M$79.8M
Research and development$304.0M$200.8M$73.4M
Sales and marketing$79.8M$123.7M$20.0M
General and administrative$88.1M$94.3M$15.9M
Total operating expenses$471.8M$418.8M$109.3M
Operating income (loss)$173.4M-$116.1M-$29.5M
Interest income$44.7M$34.3M$6.5M
Income (loss) before income taxes$218.2M-$81.8M-$22.9M
Income tax (benefit) provision-$981.0K$1.6M$3.3M
Net income (loss)$219.1M-$83.4M-$26.3M
Basic (in dollars per share)$1.32-$0.64-$0.71
Diluted (in dollars per share)$1.22-$0.64-$0.71
Basic (in shares)166.4M shares131.3M shares37.1M shares
Diluted (in shares)179.6M shares131.3M shares37.1M shares
Unrealized gain on marketable securities, net of taxes$3.9M$167.0K$488.0K
Total comprehensive income (loss)$223.0M-$83.3M-$25.8M

Compare Astera Labs with another company

Corporate structure

Astera Labs sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Astera Labs

  • FMR LLC Filed SCHEDULE 13G/A on Astera Labs, latest Oct 7, 2026 (3 filings since Apr 10, 2024)
  • BlackRock Filed SCHEDULE 13G/A on Astera Labs, latest Jul 27, 2026 (3 filings since Oct 17, 2025)
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on Astera Labs, latest Mar 26, 2026 (3 filings since Jan 30, 2025)
  • Jitendra Mohan Filed SCHEDULE 13G/A on Astera Labs, latest Nov 14, 2025 (2 filings since Nov 19, 2024)
  • Sanjay Gajendra Filed SCHEDULE 13G/A on Astera Labs, latest Nov 14, 2025 (2 filings since Nov 19, 2024)
  • AllianceBernstein Filed SCHEDULE 13G/A on Astera Labs, latest Aug 13, 2025 (2 filings since May 14, 2025)
  • Atreides Management, LP Filed SCHEDULE 13G/A on Astera Labs, latest Feb 14, 2025 (2 filings since Nov 14, 2024)
  • Astera Labs Wilmington, Delaware, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Astera Labs reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$103.8M8 Dec 31, 2025$41.5M8 Dec 31, 2024+150.1%
Accumulated depreciation$11.7M8 Dec 31, 2025$5.8M8 Dec 31, 2024+101.0%
Property and equipment, net$92.0M8 Dec 31, 2025$35.7M8 Dec 31, 2024+158.2%
Operating-lease assets (leased space)$22.8M8 Dec 31, 2025$3.0M8 Dec 31, 2024+664.7%

Real estate and locations

ItemLatestA year beforeChange
Area of real estate154,231 sq ft8 Dec 16, 2024

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$167.6M8 Dec 31, 2025$79.6M8 Dec 31, 2024+110.7%
Marketable securities, current$1.0B8 Dec 31, 2025$834.8M8 Dec 31, 2024+22.3%
Debt securities available for sale$1.0B8 Dec 31, 2025$834.8M8 Dec 31, 2024+22.3%

Inventory

ItemLatestA year beforeChange
Inventory, total$59.0M8 Dec 31, 2025$43.2M8 Dec 31, 2024+36.5%
Raw materials$84.0K8 Dec 31, 2025$229.0K8 Dec 31, 2024−63.3%
Work in process$35.8M8 Dec 31, 2025$26.7M8 Dec 31, 2024+33.9%
Finished goods$23.1M8 Dec 31, 2025$16.3M8 Dec 31, 2024+42.1%

Properties, in its own words

Our corporate headquarters is located in San Jose, California, where we currently lease approximately 154,231 square feet for office space, research and development, and testing, pursuant to a lease agreement that expires in November 2032. We also lease additional facilities in Irvine and Texas in United States, Canada, Germany, India, Singapore, and Vietnam for research and development, in China and Taiwan for local customer support and sales, and in Israel for research and development and local customer support.

We believe that our facilities are suitable to meet our current needs.

Item 2 of the 10-K filed Feb 20, 2026.12

The story

Astera Labs was founded in November 2017 in Santa Clara, California, by Jitendra Mohan, Sanjay Gajendra, and Casey Morrison. While working at Texas Instruments, the co-founders observed that while processors used in data centers were getting faster, the connectivity technologies were not keeping pace, resulting in bottlenecks. The trio quit their jobs and founded Astera in Sanjay Gajendra's garage. They adopted a fabless semiconductor model, outsourcing manufacturing to partners such as TSMC.

In April 2022, the company opened a research and development design center in Markham, Ontario. It opened another design center in Burnaby, British Columbia, in September 2022.

In May 2024, the company expanded operations in Taiwan to strengthen collaboration with original design manufacturers.

In September 2024, the company opened a research and development design center in Bengaluru, India.

In June 2025, the company relocated its headquarters to San Jose, California, tripling its size.

In January 2026, the company acquired aiXscale Photonics.

In February 2026, the company opened a design centre in Tel Aviv and offices in Ramat Gan and Haifa. It also paid approximately $70 million to form a partnership with Pliops, in which 60 employees moved from Pliops to Astera Labs.

Funding history

In March 2018, the company raised $8.5 million in a Series A round, selling shares for $0.20 each and valuing the company at $19 million. Investors included Avigdor Willenz, Intel Capital, Ron Jankov, and Sutter Hill Ventures.

Read the full text

In April 2020, the company raised $26 million in a Series B round, selling shares for $0.78 each and valuing the company at $107 million. Investors included Avigdor Willenz, Intel Capital, Ron Jankov, and Sutter Hill Ventures.

In September 2021, the company raised $52 million in a Series C round, selling shares for $6.72 each and valuing the company at $950 million. Investors included Avigdor Willenz, Intel Capital, Ron Jankov, and Sutter Hill Ventures as well as Valor Equity Partners, Venturetech Alliance, and Atreides Management.

In November 2022, the company raised $150 million in a Series D round, selling shares for $20.34 each and valuing the company at $3.16 billion. Investors included Atreides Management, Fidelity Investments, Intel Capital, and Sutter Hill Ventures.

In March 2024, the company became a public company via an initial public offering, raising $713 million by selling shares for $36 each.

From Wikipedia’s article on Astera Labs, shared under CC BY-SA 4.0.7

Leadership

Who has led Astera Labs, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Jitendra Mohan2024–now

President

  1. Sanjay Gajendra2025–now

Chief financial officer

  1. Michael Truett Tate2024–2026
  2. Desmond Lynch2026–now

Chief operating officer

  1. Sanjay Gajendra2025–now
20202025
Board members and other officers (11)

Timeline

  1. Aug 4, 20268-K Results of operations26
  2. Jun 8, 20268-K Shareholder vote27
  3. May 5, 20268-K Results of operations28
  4. Feb 10, 20268-K Entered a material agreement; Unregistered sale of shares29
  5. Feb 10, 20268-K Results of operations30
  6. Feb 10, 20268-K Executive or director change31
  7. Jan 20, 20268-K Executive or director change32
  8. Nov 4, 20258-K Results of operations33
  9. Oct 22, 20258-K Other events34
  10. Aug 5, 20258-K Results of operations35
  11. Jun 10, 20258-K Shareholder vote36
  12. May 6, 20258-K Results of operations37
  13. Mar 20, 2024Went public Listed on NASDAQ1
  14. Mar 19, 2024New chief executive Jitendra Mohan becomes CEO13
  15. 2017Founded Founded1

Calendar

Coming up

  1. Nov 3, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $0.26 a share, on Nov 4, 2025.38

When it reported results

  1. Aug 4, 2026Reported quarterly or annual results26
  2. May 5, 2026Reported quarterly or annual results28
  3. Feb 10, 2026Reported quarterly or annual results30
  4. Nov 4, 2025Reported quarterly or annual results33
  5. Aug 5, 2025Reported quarterly or annual results35
  6. May 6, 2025Reported quarterly or annual results37
  7. Feb 10, 2025Reported quarterly or annual results39
  8. Nov 4, 2024Reported quarterly or annual results40

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

412 filings to the SEC since October 2021: 2 annual reports, 8 quarterly reports, 21 major events, 199 insider forms, 17 large holders, 165 other. The latest 20:

  1. Oct 9, 20264 EDGAR
  2. Oct 9, 20264 EDGAR
  3. Oct 9, 20264 EDGAR
  4. Oct 7, 2026144 EDGAR
  5. Oct 7, 2026SCHEDULE 13G/A EDGAR
  6. Sep 3, 20264 EDGAR
  7. Sep 3, 20264 EDGAR
  8. Sep 2, 2026144 EDGAR
  9. Sep 1, 2026144 EDGAR
  10. Sep 1, 2026144 EDGAR
  11. Sep 1, 2026144 EDGAR
  12. Aug 19, 20264 EDGAR
  13. Aug 19, 20264 EDGAR
  14. Aug 19, 20264 EDGAR
  15. Aug 10, 20264 EDGAR
  16. Aug 6, 2026144 EDGAR
  17. Aug 5, 202610-Q EDGAR
  18. Aug 4, 20268-K EDGAR
  19. Jul 27, 2026SCHEDULE 13G/A EDGAR
  20. Jul 22, 20264 EDGAR

The 412 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

153 open-market trades by officers, directors and large owners since October 2021: 3 buys and 150 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 2, 2026Dyckerhoff Stefan ADirectorSale12,499$274.96$3.4MForm 4
Sep 1, 2026ALBA MANUELDirectorSale183,000$280.13$51.3MForm 4
Aug 17, 2026Gajendra SanjayPresident and COOSale90,630$340.35$30.8MForm 4
Aug 17, 2026Mazzara PhilipGeneral Counsel and SecretarySale6,801$340.50$2.3MForm 4
Aug 17, 2026Mohan JitendraChief Executive OfficerSale90,630$340.35$30.8MForm 4
Aug 6, 2026Dyckerhoff Stefan ADirectorSale12,499$311.83$3.9MForm 4
Jul 1, 2026Dyckerhoff Stefan ADirectorSale12,499$450.00$5.6MForm 4
Jul 1, 2026ALBA MANUELDirectorSale8,491$458.38$3.9MForm 4
Jul 1, 2026ALBA MANUELDirectorSale37,535$447.39$16.8MForm 4
Jul 1, 2026ALBA MANUELDirectorSale136,974$442.01$60.5MForm 4
Jun 24, 2026Mayer BethanyDirectorSale686$395.04$271.0KForm 4
Jun 4, 2026LAZAR JACK RDirectorSale10,000$355.17$3.6MForm 4
Jun 3, 2026Dyckerhoff Stefan ADirectorSale12,499$364.35$4.6MForm 4
May 21, 2026Gajendra SanjayPresident and COOSale400,000$290.30$116.1MForm 4
May 21, 2026Mazzara PhilipGeneral Counsel and SecretarySale796$291.03$231.7KForm 4
May 19, 2026Gajendra SanjayPresident and COOSale280,000$249.19$69.8MForm 4
May 19, 2026Mohan JitendraChief Executive OfficerSale28,737$249.62$7.2MForm 4
May 18, 2026Gajendra SanjayPresident and COOSale95,444$225.02$21.5MForm 4
May 18, 2026Mazzara PhilipGeneral Counsel and SecretarySale14,076$231.78$3.3MForm 4
May 18, 2026Mohan JitendraChief Executive OfficerSale95,444$225.02$21.5MForm 4

All 153 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Michael TateFormer Chief Financial Officer$468.3K$6.5M48
2025Philip MazzaraGeneral Counsel and Secretary47$418.3K$3.0M48
2025Jitendra MohanCo-Founder, Chief Executive Officer52$613.8K$2.2M48
2025Sanjay GajendraCo-Founder, President, Chief Operating Officer51$613.8K$2.2M48
2024Jitendra MohanCo-Founder, Chief Executive Officer52$575.8K$50.9M48
2024Sanjay GajendraCo-Founder, President, Chief Operating Officer51$575.8K$50.9M48
2024Michael TateFormer Chief Financial Officer$438.3K$5.5M48
2024Philip MazzaraGeneral Counsel and Secretary47$392.5K$2.4M48
2023Michael TateFormer Chief Financial Officer$309.2K$1.5M48
2023Philip MazzaraGeneral Counsel and Secretary47$309.2K$1.2M48
2023Jitendra MohanCo-Founder, Chief Executive Officer52$309.2K$492.1K48

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Fmr LLC24,845,364$12.0B0.5%−684,521
BlackRock, Inc.13,683,865$6.6B0.1%+2,234,096
Vanguard Portfolio Management LLC7,887,650$3.8B0.2%+577,872
Vanguard Capital Management LLC6,727,089$3.2B0.1%+386,357
Invesco Ltd.4,910,555$2.4B0.2%+4,540,375
State Street Corp3,678,093$1.8B0.1%+344,487
Geode Capital Management, LLC2,796,173$1.3B0.1%+287,909
Van Eck Associates Corp2,237,961$1.1B0.7%+373,545
Bank Of America Corp /de/2,198,235$1.1B0.1%+410,003
Morgan Stanley1,686,491$814.6M0.0%−45,857
Jpmorgan Chase & Co1,775,810$809.7M0.0%+1,345,421
Amundi1,591,888$768.9M0.2%−288,942
Whale Rock Capital Management LLC1,567,882$757.3M6.1%New
Norges Bank1,434,347$692.8M0.1%New
Citigroup Inc1,352,136$653.1M0.3%−160,918
Rafferty Asset Management, LLC1,321,419$638.3M1.5%+375,913
Fred Alger Management, LLC1,283,840$620.1M2.1%−1,289,165
Goldman Sachs Group Inc1,234,152$596.1M0.1%−145,962
Atreides Management, LP1,216,795$587.7M5.3%−2,148,992
Barclays PLC1,130,944$546.3M0.2%−423,236
Maverick Capital Ltd1,067,215$515.5M4.7%+111,859
Federated Hermes, Inc.938,311$453.2M0.7%+666,054
Vanguard Fiduciary Trust Co884,834$427.4M0.1%+33,073
Northern Trust Corp870,775$420.6M0.0%+66,114
Fuller & Thaler Asset Management, Inc.857,286$414.1M1.1%+22,626

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

2 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Feb 27, 2025Robert P. Bresnahan, Jr.Republican, HouseSale$1,001 - $15,000−245.4%Report
Feb 18, 2025Robert P. Bresnahan, Jr.Republican, HouseSale$1,001 - $15,000−180.2%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Astera Labs is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAstera Labs, Inc.2
  • CIK0001736297
  • Employer ID (EIN)82-343706212
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company12
  • Incorporated inDelaware12
  • Fiscal year endsDecember 312
  • Industry code (SIC)3674 Semiconductors & Related Devices2
  • SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance2
  • Business address2345 North First Street, San Jose, CA 951312
  • Phone408-766-38062
  • Shares outstanding173,485,104 as of Jul 31, 202611
  • Public float$13.2B as of Jun 30, 202512
  • AuditorPricewaterhouseCoopers LLP, Phoenix, Arizona PCAOB ID 238; it also attests to the company’s internal control over financial reporting12
  • On EDGAR sinceApr 5, 20182
  • Filings414 in all: 4 (184), 144 (131), 8-K (21), 3 (13), SCHEDULE 13G/A (9), 10-Q (8), S-8 (4), SC 13G (4)2
    All 29 form types

    UPLOAD (4), CORRESP (3), DRS/A (3), DRSLTR (3), S-1/A (3), SCHEDULE 13G (3), 10-K (2), 4/A (2), ARS (2), D (2), DEF 14A (2), DEFA14A (2), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), EFFECT (1), S-1 (1), S-3ASR (1), SC 13G/A (1), SD (1)

  • Latest filingsAnnual report (10-K) Feb 20, 2026
    Quarterly report (10-Q) Aug 5, 2026
    Proxy statement (DEF 14A) Apr 23, 2026
    Latest 8-K (8-K) Aug 4, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, par value $0.0001 per shareALABNasdaq

From the cover page of the 10-K filed Feb 20, 2026 (Section 12(b) of the Exchange Act).12

Risk factors and legal proceedings

The risks Astera Labs names in Item 1A of its 10-K filed Feb 20, 2026: 63 risks under these headings, as written.12

  • Risks Related to Our Business
  • Risks Related to Our Industry
  • Risks Related to our Intellectual Property
  • Risks Related to the Ownership of Our Common Stock
  • We may not sustain our growth rate, and we may not be able to manage future growth effectively.
  • We have a limited history of generating net income, and if we are unable to achieve adequate revenue growth while our expenses increase, we may not maintain profitability in the future.
  • We have rapidly grown as a business in dynamic and rapidly evolving markets, and we may have difficulty accurately predicting our future revenue for the purpose of appropriately budgeting and adjusting our expenses.
  • We may be unsuccessful in anticipating and responding to new market trends and evolving industry standards, developing and selling new products, or penetrating new markets.
  • A substantial portion of our revenue is driven by a limited number of our end customers, and the loss of, or a significant reduction in, demand from one or a few of our top end customers would adversely affect our operations and financial condition.
  • If we fail to achieve design wins for our products, we may lose the opportunity for sales to customers for a significant period of time and be unable to recoup our investments in our products.
  • We may experience difficulties demonstrating to customers the value of our new products or newer generations of our existing products.
  • The adoption, use, and commercialization of AI technology, and the continued rapid pace of developments in the AI field, are inherently uncertain. Failure by our customers to continue to adopt or invest in AI infrastructure to support AI use cases in their systems, or our ability to keep up with evolving AI infrastructure requirements, could have a material adverse effect on our business, financial condition, and results of operations.
The other 55 risks
  • We rely on a limited number of third-party manufacturing partners for our manufacturing and supply chain services, and the failure to manage our relationships successfully with our third-party manufacturing partners in order to obtain adequate services and supplies could adversely affect our ability to market and sell our products and our reputation.
  • Our third-party manufacturing partners and distributors, and the majority of our revenue, are concentrated primarily in Singapore, China, Taiwan, South Korea, and other countries, areas that are or may be subject to geopolitical uncertainty, trade disputes and restrictions, environmental disasters, and other risks. Any disruption to the operations of these manufacturing partners or distributors could cause significant delays in the production or shipment of our products and impact our financial condition.
  • Our customers require our products and our third-party manufacturing partners to undergo a lengthy and expensive qualification process, which does not assure volume product sales. If we are unsuccessful or delayed in qualifying any of our products with a customer, our business and operating results would suffer.
  • We make substantial investments in research and development, and unsuccessful investments could materially adversely affect our business, financial condition, and results of operations.
  • Our future success will depend in large part on our ability to successfully execute our strategy.
  • Our gross margins may decline due to a variety of factors, which could negatively impact our results of operations and our financial condition.
  • Pricing for the current generation of our existing products often decreases over time, which could negatively impact our revenue and gross margins.
  • Fluctuations in the mix of products sold may materially adversely affect our gross margins and financial results.
  • We may pursue acquisitions, investments, joint ventures, and dispositions, which could adversely affect our results of operations, and any acquisitions we do make could disrupt our business and harm our financial condition.
  • If we are unable to accurately predict end customer demand, or if our distributors or end customers’ manufacturing partners cancel or change their orders, we may hold excess or obsolete inventory, which would reduce our gross margins and may damage our relationships with our customers.
  • We generally do not maintain long-term supply contracts with our third-party manufacturing partners, and any disruption in our supply of products could have a material adverse effect on our business, financial condition, and results of operations.
  • We rely on our relationships with leaders in the data center and AI infrastructure ecosystem to test and validate our products at a system level and our inability to continue to develop or maintain such relationships in the future would harm our ability to remain competitive.
  • The complexity of our products could result in unforeseen delays or expense or undetected defects, bugs, or security vulnerabilities, which could adversely affect the market acceptance of new products, damage our reputation with current or prospective customers, and materially and adversely affect our operating costs.
  • Adverse changes in the political, regulatory, and economic policies of governments in connection with trade with China and Chinese customers have reduced the demand for our products and damaged our business.
  • If the third-party manufacturing partners, including manufacturers and assembly and test providers, with which we contract, or any additional third-party manufacturing partners with which we may contract in the future, do not achieve satisfactory yields or quality, our reputation and customer relationships could be harmed.
  • Our operating results are impacted by wide fluctuations of supply and demand in the industry.
  • We previously identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain an effective system of internal control over financial reporting. Although these material weaknesses have been remediated, if we fail to develop and maintain effective internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired, which could harm our business and negatively impact the value of our common stock.
  • We may experience difficulties in transitioning to smaller geometry process nodes, and tapeouts in smaller nodes are more expensive.
  • If we are unable to attract, train, and retain qualified personnel, particularly our design and technical personnel, we may not be able to execute our business strategy effectively.
  • Our business would be adversely affected by the departure of existing members of our senior management team.
  • Cybersecurity risks, including cyber-attacks, cybersecurity incidents, data breaches, and system vulnerabilities could adversely affect our business and disrupt our operations.
  • An impairment of the confidentiality, integrity, or availability of our IT systems, or those of one or more of our IT vendors could have a material adverse effect on our business.
  • We are in the process of transitioning to a new enterprise resource planning system (“ERP”), and our assessment of readiness, prioritization of resources, and any delays or difficulties associated with the design, implementation, or post-implementation use of our new ERP system could adversely impact our business, financial condition, and results of operations.
  • We may be subject to warranty claims and product liability.
  • Litigation and other legal proceedings may adversely affect our business.
  • The occurrence of events for which we are self-insured, or which exceed our insurance limits, may adversely affect our profitability and liquidity.
  • Our business, financial condition, and results of operations could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which we conduct business.
  • We may not be able to accurately predict our future capital needs, and we may not be able to obtain additional financing to fund our operations.
  • If our estimates or judgments relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our results of operations could fall below expectations of securities analysts and investors, resulting in a decline in the market price of our common stock.
  • Our reported financial results may be adversely affected by new accounting pronouncements or changes in existing accounting standards and practices.
  • A pandemic, epidemic, or outbreak of an infectious disease may materially and adversely affect our business and our financial results.
  • Changes in current or future laws or regulations or the imposition of new laws or regulations by federal or state agencies or foreign governments could impair our ability to compete in international markets, or subject us to criminal penalties or significant fines, which may adversely affect our business and reputation.
  • Our global operations expose us to numerous legal and regulatory requirements and failure to comply with such requirements, including unexpected changes to such requirements, could adversely affect our results of operations.
  • Regulatory authorities in jurisdictions into or from which we ship our products or import supplies could levy fines, restrict or delay our ability to export products or import supplies, or increase costs associated with the manufacture or transfer of products.
  • Customer demands for us to implement business practices that are more stringent than legal requirements may reduce our revenue opportunities or cause us to incur higher costs.
  • Changes in existing tax laws, tax rules, or tax practices may adversely affect our financial results.
  • We operate in intensely competitive markets. Our failure to compete effectively, including as a result of industry consolidation, would harm our results of operations.
  • Unfavorable or uncertain conditions in the cloud market, as well as for AI infrastructures, may cause fluctuations in our rate of revenue growth or financial results.
  • Raw material price fluctuations or decreased availability of certain raw materials can increase the cost of our products, impact our ability to meet customer commitments, and may adversely affect our business, financial condition, and results of operations.
  • Our customers rely on many different service providers and component suppliers to build their systems, and the frequency at which our products are purchased by our customers and incorporated into their systems may vary.
  • Our failure to protect our intellectual property rights adequately could impair our ability to compete effectively or to defend ourselves from litigation, which could harm our business, financial condition, and results of operations.
  • We utilize a significant amount of intellectual property in our business. If we are unable or fail to protect our intellectual property, our business could be adversely affected.
  • We rely on third-party technologies for the development of our products and our inability to use such technologies in the future would harm our ability to remain competitive.
  • We may face claims of intellectual property infringement, misappropriation or other violations, which could be time-consuming or costly to defend or settle, result in the loss of significant rights or harm our relationships with our customers or reputation in the industry.
  • Any potential dispute involving patents or other intellectual property could affect our customers, which could trigger our indemnification obligations to them and result in substantial expense to us.
  • Our IPO occurred in March 2024. As such, there has only been a public market for our common stock for a relatively short period of time. The market price of our common stock may continue to be volatile, which could cause the value of your investment to decline, and we may not be able to meet investor or analyst expectations.
  • Our revenue and operating results can fluctuate from period to period, which could cause our share price to fluctuate.
  • Sales of substantial amounts of our common stock in the public markets or the perception that sales might occur, could cause the trading price of our common stock to decline.
  • Our issuance of additional capital stock in connection with financings, acquisitions, investments, our stock incentive plans, or otherwise will dilute all other stockholders and could negatively affect our results of operations.
  • Our executive officers, directors, and stockholders, if they choose to act together, have the ability to control or significantly influence all matters submitted to shareholders for approval.
  • Provisions in our charter documents and under Delaware law could make an acquisition of our company more difficult, limit attempts by our stockholders to replace or remove our current board of directors, and limit the trading price of our common stock.
  • If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research, about our business, the trading price of our common stock and trading volume could be adversely affected.
  • We do not expect to declare or pay any dividends on our common stock for the foreseeable future.
  • Our second amended and restated bylaws designate specific courts as the sole and exclusive forum for certain disputes that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.
  • General Risk Factors
  • We have incurred, and will continue to incur, increased costs as a result of operating as a public company, and our management is required to devote substantial time to support compliance with our public company responsibilities and corporate governance practices.

Legal proceedings

We are not currently a party to any material pending legal proceedings. From time to time, we may be subject to legal proceedings and claims arising in the ordinary course of business. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.

The opening of Item 3, Legal Proceedings.12

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Yahoo FinanceALAB quote
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
    SEC EDGAROther events
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48